Overview

Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer

Status:
Unknown status

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

Effect of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer. The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.

Phase:

N/A

Details

Lead Sponsor:

Hanjong Ahn

Treatments:

Docetaxel